|
Market Closed -
Nasdaq
02:30:00 11/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 253.25 USD | -0.64% |
|
+1.74% | +43.90% |
| 09/11 | UCB And Biogen Announce Clinical Profile Data For Dapirolizumab Pegol In Systemic Lupus Erythematosus | CI |
| 29/10 | Biogen Presents New Data Across Alzheimer?S Disease Portfolio At CTAD 2026 | CI |
| Market Cap | 3.74TCr 3.36TCr 3.09TCr 2.81TCr 5.32TCr 3,51000Cr 5.47TCr 37TCr 15TCr 1,88000Cr 14TCr 14TCr 5,94500Cr | P/E 2026 * |
51.1x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.31TCr 3.86TCr 3.56TCr 3.23TCr 6.12TCr 4,03800Cr 6.29TCr 43TCr 17TCr 2,16400Cr 16TCr 16TCr 6,83900Cr | EV / Sales 2026 * |
4.07x | EV / Sales 2027 * | 3.76x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Xetra
| IDP | Delayed | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | -0.64% | ||
| 1 week | +1.74% | ||
| Current month | -0.15% | ||
| 1 month | +12.20% | ||
| 3 months | +22.27% | ||
| 6 months | +30.91% | ||
| Current year | +43.90% |
| 1 week | 240 |  | 261 |
| 1 month | 226.71 | | 261 |
| Current year | 160.36 | | 261 |
| 1 year | 158.05 | | 261 |
| 3 years | 110.04 | | 268.3 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/10/26 | Exercice | Chief Technology Officer | 1,735 | 0.0012% | ||
| 02/10/26 | Exercice | Controller/Auditor | 62 | 0.0000% | ||
| 01/09/26 | Free | General Counsel | 7,405 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.64% | +1.74% | +62.07% | +12.66% | 3.77TCr | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,25800Cr | |
| -0.47% | +5.49% | +49.03% | +90.68% | 68TCr | |
| +0.20% | +2.76% | +34.37% | +112.06% | 52TCr | |
| +0.17% | +2.76% | +44.07% | +69.71% | 39TCr | |
| -0.48% | +2.34% | +70.66% | +46.02% | 37TCr | |
| +0.76% | +2.27% | +31.59% | +60.36% | 31TCr | |
| -1.29% | +0.90% | +5.77% | +37.60% | 29TCr | |
| 0.00% | +0.86% | +43.74% | +74.04% | 25TCr | |
| +0.92% | +2.03% | +44.62% | +125.07% | 21TCr | |
| Average | -0.09% | +1.18% | +43.41% | +76.78% | 43TCr | |
| Weighted average by Cap. | -0.10% | +1.19% | +43.82% | +96.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.06TCr 948.35Cr 874Cr 793.74Cr 1.5TCr 99TCr 1.54TCr 10TCr 4.17TCr 53TCr 3.97TCr 3.88TCr 1,67900Cr | 1.08TCr 966.48Cr 890.71Cr 808.91Cr 1.53TCr 1,01000Cr 1.57TCr 11TCr 4.25TCr 54TCr 4.04TCr 3.96TCr 1,71100Cr |
| Net income | 79Cr 71Cr 65Cr 59Cr 111.94Cr 7.39TCr 115.06Cr 779.81Cr 310.69Cr 3.96TCr 295.73Cr 289.46Cr 13TCr | 178.65Cr 160.22Cr 147.65Cr 134.09Cr 253.78Cr 17TCr 260.87Cr 1.77TCr 704.39Cr 8.97TCr 670.46Cr 656.24Cr 28TCr |
| Net Debt | 563.44Cr 505.29Cr 465.67Cr 422.91Cr 800.39Cr 53TCr 822.73Cr 5.58TCr 2.22TCr 28TCr 2.11TCr 2.07TCr 89TCr | 308.1Cr 276.31Cr 254.64Cr 231.26Cr 437.67Cr 29TCr 449.89Cr 3.05TCr 1.21TCr 15TCr 1.16TCr 1.13TCr 49TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $253.25 | -0.64% | 7,35,003 |
| 09/26/09 | $254.87 | +2.63% | 11,43,244 |
| 06/26/06 | $248.35 | +1.81% | 10,02,119 |
| 05/26/05 | $243.93 | -4.14% | 12,21,066 |
| 04/26/04 | $254.46 | +2.22% | 13,48,003 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
